Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L).

Taichi MiyawakiHirotsugu KenmotsuHideyuki HaradaYasuhisa OhdeYasutaka ChibaKoji HarataniTamio OkimotoTomohiro SakamotoKazushige WakudaKentaro ItoTakehiro UemuraShinya SakataYoshihito KogureYasumasa NishimuraKazuhiko NakagawaNobuyuki Yamamoto

Published in: BMC cancer (2021)

jRCT identifier: jRCTs041200046 (date of initial registration: 28 October 2020).

Keyphrases

phase ii study
open label
locally advanced
advanced non small cell lung cancer
randomized controlled trial
radiation therapy
tyrosine kinase